De Novo Expression of Transfected Human Class 1 Aldehyde Dehydrogenase (ALDH) Causes Resistance to Oxazaphosphorine Anti-cancer Alkylating Agents in Hamster V79 Cell Lines
Open Access
- 1 May 1996
- journal article
- Published by Elsevier
- Vol. 271 (20) , 11884-11890
- https://doi.org/10.1074/jbc.271.20.11884
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenaseBiochemical Pharmacology, 1994
- Cloning and Expression of the Full‐Length cDNAS Encoding Human Liver Class 1 and Class 2 Aldehyde DehydrogenaseAlcohol, Clinical and Experimental Research, 1993
- Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistanceBiochemical Pharmacology, 1993
- Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehydeBiochemical Pharmacology, 1992
- Aldehyde Dehydrogenases and Their Role in CarcinogenesisCritical Reviews in Biochemistry and Molecular Biology, 1992
- Identification of mouse liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acidBiochemical Pharmacology, 1991
- Lipid aldehyde oxidation as a physiological role for class 3 aldehyde dehydrogenasesBiochemical Pharmacology, 1991
- Human and Mouse Hepatic Aldehyde Dehydrogenases Important in the Biotransformation of Cyclophosphamide and the RetinoidsPublished by Springer Nature ,1990
- Xen0biotic Oxidation Catalyzed by Aldehyde DehydrogenasesDrug Metabolism Reviews, 1989
- Metabolism of oxazaphosphorinesPharmacology & Therapeutics, 1988